Magnetic Resonance Elastography Of Chronic Low Back Pain Before And After Therapy
Magnetic Resonance Elastography Assessment Of Chronic Low Back Pain Before And After A Manual Therapy Intervention
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Melissa Bush
- Telefonnummer: 507-266-1008
- E-post: Bush.Melissa1@mayo.edu
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forente stater, 55905
- Mayo Clinic in Rochester
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Adult males or females (age ≥ 18 years)
- Report chronic low back pain (≥3 months) (measured by patient history and clinical evaluation)
- Pain intensity reported at baseline must be ≥4 on the pain VAS scale
- Presence of myofascial pain features in the lumbar region (e.g., localized tenderness and/or trigger points identified by a qualified clinician/therapist)
- Able to lie in supine and prone positions for study procedures
- Be able to participate fully in all aspects of the study
- Have understood and signed study informed consent
Exclusion Criteria:
- Pregnancy or breastfeeding
- Patients with the inability to stay in a prone and supine position for the required procedure durations (e.g., ≥30 minutes at a time)
- Any contraindication to an MRI exam, or severe claustrophobia that would prevent safe completion of the scan
- Previous lumbar spine surgery or history of severe lumbar injury (e.g., fracture) that, in the investigation team's judgment, would interfere with participation or safety
- Patients with known bleeding disorders or current therapeutic anticoagulation that would increase risk of bruising/bleeding with massage
- Patients with skin conditions affecting the treatment area (e.g., rash, open wound, active dermatitis) or known allergy to any materials used during treatment (e.g., gels/cleaners), if applicable
- Receipt of a new pain treatment within 3 days of the study visit (e.g., injection, ablation, spinal manipulation, massage/manual therapy) that could confound pre/post measures
- Use of short-acting opioid analgesics or sedating medications within 24 hours of the study visit
- Have an implanted device in or near the treatment area that could interfere with safe application of external pressure
- Have used an investigational drug within 30 days of study enrollment
- History of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease.
- Clinically significant unstable neurologic or systemic illness that would preclude safe participation, as judged by the investigation team.
- Surgical intervention for pain within 1 month prior to enrollment
- Active infection, wound, or other external trauma to the areas to be treated
- Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
- Inability to provide consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Expert Manipulative Massage Automation (EMMA)
Subjects will receive one massage therapy session utilizing the EMMA system
|
Participants will receive device-assisted massage therapy using EMMA (Expert Manipulative Massage Automation).
Each treatment session will last approximately 30 minutes.
The device will be operated using conservative settings with predefined maximum force and pressure limits.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Change in SII-derived mobility index
Tidsramme: Baseline, 30 minutes post-intervention
|
Baseline, 30 minutes post-intervention
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Pain, Enjoyment of Life, and General Activity (PEG) Scale Score
Tidsramme: Baseline, 30 minutes post-intervention
|
The Pain, Enjoyment of Life, and General Activity (PEG) scale is a 3-item participant-reported measure used to assess pain intensity and pain-related interference with enjoyment of life and general activity.
The total PEG score is calculated as the average of the 3 item scores and ranges from 0 to 10, with higher scores indicating greater pain severity and interference.
|
Baseline, 30 minutes post-intervention
|
|
Change in Spinal Range of Motion (ROM)
Tidsramme: Baseline, 30 minutes post-intervention
|
Spinal range of motion will be assessed by a clinical assessor using a bubble inclinometer.
Measurements will include lumbar flexion and right and left lateral bending.
The outcome will be reported as the change from baseline in spinal range of motion, measured in degrees.
|
Baseline, 30 minutes post-intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Ziying Yin, Ph.D., Mayo Clinic
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 26-002257
- INTERSHIELD 26-002257 (Annet stipend/finansieringsnummer: Mayo Clinic Radiology)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .